FDA Inspection
Midlab IncorporatedMidlab Incorporated – FDA Inspection, Aug 5, 2022
Record Details
This FDA Inspection record concerns Midlab Incorporated, with an inspection on August 5, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Midlab Incorporated
- Inspection Date
- August 5, 2022
- Product Type
- Drugs
View Company Profile
ID · 3ccb23b9-ac82-422d-ad74-de012c50676f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1177708
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
FDA Citations
6- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.84(d)(1)Component identity verification
- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.115(a)Reprocessing procedures not written or followed
- 21 CFR 211.22(a)Approve or reject components, products
- 21 CFR 211.166(a)Lack of written stability program
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Midlab Incorporated
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 13, 2024 | OAI | New Orleans District Office | Drug Quality Assurance |
| May 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Midlab Incorporated
- FDA Inspection 1249514 - 2024-09-13
- FDA Inspection 1021846 - 2017-05-24
- FDA Inspection 767524 - 2012-02-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.